Hills Bank & Trust Co. lessened its holdings in shares of Cigna Corp (NYSE:CI) by 53.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,288 shares of the health services provider’s stock after selling 3,798 shares during the period. Hills Bank & Trust Co.’s holdings in Cigna were worth $529,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also modified their holdings of the company. 1 North Wealth Services LLC purchased a new stake in shares of Cigna in the 4th quarter valued at approximately $25,000. Clarfeld Financial Advisors LLC purchased a new stake in shares of Cigna in the 4th quarter valued at approximately $25,000. Private Ocean LLC purchased a new stake in shares of Cigna in the 4th quarter valued at approximately $26,000. Delta Asset Management LLC TN purchased a new stake in shares of Cigna in the 4th quarter valued at approximately $28,000. Finally, Litman Gregory Asset Management LLC purchased a new stake in shares of Cigna in the 4th quarter valued at approximately $30,000. 88.61% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have recently issued reports on the stock. ValuEngine upgraded shares of Cigna from a “strong sell” rating to a “sell” rating in a report on Thursday, April 25th. Zacks Investment Research cut shares of Cigna from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 20th. Morgan Stanley reduced their target price on shares of Cigna from $304.00 to $299.00 and set an “overweight” rating for the company in a research note on Tuesday, February 5th. Barclays reduced their target price on shares of Cigna from $220.00 to $207.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $245.00 price target on shares of Cigna in a report on Sunday, April 21st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $225.62.
Cigna (NYSE:CI) last issued its quarterly earnings results on Thursday, May 2nd. The health services provider reported $3.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.74 by $0.16. Cigna had a net margin of 4.11% and a return on equity of 14.23%. The business had revenue of $33.43 billion during the quarter, compared to analyst estimates of $32.79 billion. During the same quarter in the previous year, the firm earned $4.11 earnings per share. The business’s revenue was up 192.9% compared to the same quarter last year. Equities research analysts predict that Cigna Corp will post 16.46 earnings per share for the current year.
The firm also recently declared a special dividend, which was paid on Wednesday, April 10th. Shareholders of record on Monday, March 11th were given a $0.04 dividend. The ex-dividend date was Friday, March 8th. Cigna’s dividend payout ratio (DPR) is presently 0.28%.
In related news, insider Brian C. Evanko acquired 2,000 shares of the business’s stock in a transaction on Monday, March 11th. The shares were purchased at an average price of $163.40 per share, for a total transaction of $326,800.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director William D. Zollars sold 272 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $168.43, for a total value of $45,812.96. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by insiders.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Read More: How to Invest in a Bull Market
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.